Second quarter 2020 total revenue of $37.5 millionReceived U.S Food and Drug Administration (“FDA”) approval for Upneeq™ (oxymetazoline hydrochloride ophthalmic […]
SOUTH SAN FRANCISCO, Calif., Aug. 11, 2020 (GLOBE NEWSWIRE) — Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today reported financial results for the […]
Strong Business Model Demonstrates Resilience By Generating Record $1.8 Million in Positive Cash Flow from OperationsBusiness Experiencing Positive Trends Since […]